Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Anasetti

Showing results (121-130 of 222) with videos related to

Pageof 23
Sort By:
Blood|May 15, 1992
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholoneK Doney, M Pepe, R Storb, et al.
Blood|May 15, 1992
Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donorsJ Nemunaitis, C Anasetti, R Storb, et al.
Blood|May 1, 1989
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Blood|September 1, 1990
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?R Storb, M Pepe, C Anasetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patientsJ T Slattery, T F Kalhorn, G B McDonald, et al.
Bone Marrow Transplantation|August 18, 2009
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHDU Gergis, K Markey, J Greene, et al.
Seminars in Hematology|July 1, 1991
Marrow transplantation for severe aplastic anemia and thalassemia majorR Storb, C Anasetti, F Appelbaum, et al.
Blood|June 1, 1994
Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donorsH J Deeg, C Anasetti, E Petersdorf, et al.
Blood|May 1, 1994
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemiaR Storb, W Leisenring, H J Deeg, et al.
Blood|June 15, 1995
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center studyR A Nash, R Etzioni, R Storb, et al.
Pageof 23

Showing results (121-130 of 222) with videos related to

Sort By:
Pageof 23
Blood|May 15, 1992
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholoneK Doney, M Pepe, R Storb, et al.
Blood|May 15, 1992
Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donorsJ Nemunaitis, C Anasetti, R Storb, et al.
Blood|May 1, 1989
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trialR Storb, H J Deeg, M Pepe, et al.
Blood|September 1, 1990
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?R Storb, M Pepe, C Anasetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patientsJ T Slattery, T F Kalhorn, G B McDonald, et al.
Bone Marrow Transplantation|August 18, 2009
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHDU Gergis, K Markey, J Greene, et al.
Seminars in Hematology|July 1, 1991
Marrow transplantation for severe aplastic anemia and thalassemia majorR Storb, C Anasetti, F Appelbaum, et al.
Blood|June 1, 1994
Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donorsH J Deeg, C Anasetti, E Petersdorf, et al.
Blood|May 1, 1994
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemiaR Storb, W Leisenring, H J Deeg, et al.
Blood|June 15, 1995
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center studyR A Nash, R Etzioni, R Storb, et al.
Pageof 23